| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |